Eventide Asset Management »

Soleno Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $32M 467k 67.60

More positions owned by Eventide Asset Management

Guardant Health (GH)
Mirum Pharmaceuticals (MIRM)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Insmed Com Par $.01 (INSM)
Lam Research Corp Com New (LRCX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Scholar Rock Hldg Corp (SRRK)
Beta Bionics (BBNX)
Argenx Se Sponsored Adr (ARGX)
Roper Industries (ROP)
Vistra Energy (VST)
Axsome Therapeutics (AXSM)
Toast Cl A (TOST)

View all positions for Eventide Asset Management

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vivo Capital
State Street Corporation
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Braidwell
Millennium Management
Polar Capital Holdings

View all funds holding Soleno Therapeutics